It has been confirmed that NR3C1 in pancreatic cancer is highly regulated by upstream miR-1270, and silencing NR3C1 can inhibit the malignant phenotype of pancreatic cancer cells (Wang et al., 2023). This evidence concerns the gene NR3C1 and familial pancreatic carcinoma.